SAB Gives Largely Critical Responses To EPA Science Transparency Rule

摘要

EPA science advisors are giving largely critical responses to the agency's narrow questions about how to implement protections of trade secret or personal medical information as part of its effort to advance the science transparency rule that aims to bar agency decision-makers from relying on any information that is not publicly available. Several members of the Science Advisory Board (SAB) expressed their dismay in a just-released consultation report at the limited charge they were given on the proposed rule. Some continued to question the process that EPA employed to gather input from SAB on the proposal, where the agency sought individual responses from SAB members through a "consultation" process rather than seeking a consensus report developed over multiple meetings of the SAB.